CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. — Form SCHEDULE 13D
Filed October 1, 2026 · analyzed by the Ownership Agent
SCHEDULE 13D
— Neutral
significance 18/100
What the filing says
Timothy Warbington and Creative Acquisition Corp filed a joint Schedule 13D on October 1, 2026 regarding securities of Creative Medical Technology Holdings, Inc. The filing is a joint filing agreement with no specific stake percentage, share count, or acquisition details disclosed in this exhibit. The document merely establishes consent to joint filing without substantive disclosure of the parties' beneficial ownership or intent.
Why this rating
Schedule 13D filing signals potential significant ownership stake, but this exhibit alone provides no specifics on position size, timing, or intent relative to $4.6M market cap. Requires main 13D document for materiality assessment.
See more from October 1, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.